glp-1 food industry news today Makers Warn GLP-1s Will Have 'Lasting Influence' Food makers warn GLP-1s will

Today's discussion, thanks to Dr

But it is important to draw the line clearly

Currently, the available therapeutic options for the management of PCOS remain symptomatic and, in many cases, unsatisfactory

Real-world evidence from UK and European databases suggests that patients with type 2 diabetes and fatty liver who receive GLP-1 therapy experience improvements in liver enzyme levels (ALT, AST) and non-invasive markers of fibrosis

The therapy comes with a boxed warning for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome

The effectiveness of the collagen and other active ingredients may be diminished after the expiration date, and there is also a risk of contamination or spoilage, which could cause adverse health effects